Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193965 | SCV000247651 | uncertain significance | not specified | 2014-08-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000917741 | SCV001063031 | likely benign | not provided | 2024-02-08 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002226696 | SCV002505411 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with with Neonatal Diabetes. However, no sufficient evidence is found to ascertain the role of rs114899765 variant in MODY yet. | |
Ambry Genetics | RCV002345694 | SCV002652430 | likely benign | Inborn genetic diseases | 2022-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000917741 | SCV005376781 | uncertain significance | not provided | 2023-10-20 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |